Esco Lifesciences (Esco) announced the close of an over-subscribed US$200 million Series A and Crossover round. The financing was led by Vivo Capital and Novo Holdings A/S, with participation from new investors including China Investment Corporation, Singapore-based global investor EDBI, a reputable, long-term institutional investor, and other sophisticated investors. XQ Lin, Chairman and CEO of…
Founded in 2013, Aerobiotix, a global medical company has raised a $25 million of growth equity financing. The round was led by Vivo Capital with participation by Asahi Kasei Ventures. The new funding will be used to accelerate sales, marketing, and new product development. “Healthcare doesn’t stop at the patient, it encompasses an environment which…
PatientPop, the US-based market leader in practice growth technology, announced it has secured a Series C capital round of $50 million, led by HLM Venture Partners, one of the top healthcare venture firms in the country. New investors Commonfund and Vivo Capital, and existing investors Toba Capital, Transformation Capital, and Silicon Valley Bank also participated…
Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), announced that it has raised $137 million in a Series B financing to accelerate investment in salesforce expansion, technology and product innovation and further development of clinical evidence supporting its flagship solution. The financing…